STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #888 by analyst upside · 2026-06-27
CVRX
CVRx, Inc.
Healthcare · Market Cap $156M · P/E 0x
ANALYST PRICE TARGET
+90.6%
implied upside to consensus target
Current Price $5.86
Consensus Target $11.17
Bull Target $14.0
Bear Target $6.0
Analysts Covering 6
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
4
Hold
0
Sell
1
52-Week Low $4.37
52-Week High $11.3
YTD Return -17.5%
FUNDAMENTALS
Market Cap $156M
P/E Ratio (TTM) N/A
Forward P/E -3.1x
EPS (TTM) $-2.01
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $59M
Profit Margin -89.1%
52-WEEK RANGE
52-Week Low $4.37
52-Week High $11.3
Current Price $5.86
Bear Target $6.0
Bull Target $14.0
● Now $5.86 ● Target $11.17
TRADING DATA
Avg Volume 310K
YTD Return -17.5%
Analyst Count 6
Consensus Buy
Upside to Target +90.6%
Last Updated 2026-06-27

ANALYST SUMMARY

CVRx, Inc. (CVRX) is currently trading at $5.86 with a Wall Street consensus price target of $11.17, implying potential upside of 90.6% over the next 12 months. 6 analysts currently cover CVRX, with a consensus rating of Buy — 83% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $6.0.

CVRX operates in the Healthcare sector with a market capitalisation of $156M. The stock is down 17.5% year-to-date and is currently trading near the lower end of its 52-week range of $4.37 – $11.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CVRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-04-14 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-02-13 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2025-11-06 Building track record
Cantor Fitzgerald — Reiterated
Overweight → Overweight 2025-11-06 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2025-08-05 40% win rate (10 calls)
Piper Sandler — Reiterated
Overweight → Overweight 2025-05-09 14% win rate (7 calls)
JP Morgan ↓ Downgrade
Neutral → Underweight 2025-05-09 43% win rate (7 calls)
Lake Street — Reiterated
Buy → Buy 2025-04-08 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →